The efficacy and safety of Osimertinib in advanced non-small cell lung cancer patients with Thr790Met resistance mutations: a systematic review and meta-analysis

Saijin Cui, Yaling Zhang, Lu Liu, Yan Li, Rongmiao Zhou, Xi Huang, Shiru Cao, Xiangran Huo, Na Wang